Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

OptimizeRx (OPRX) Other Working Capital Changes (2016 - 2025)

OptimizeRx's Other Working Capital Changes history spans 16 years, with the latest figure at $437000.0 for Q3 2025.

  • For Q3 2025, Other Working Capital Changes rose 129.99% year-over-year to $437000.0; the TTM value through Sep 2025 reached $749000.0, up 923.08%, while the annual FY2024 figure was $301000.0, 549.25% up from the prior year.
  • Other Working Capital Changes for Q3 2025 was $437000.0 at OptimizeRx, up from -$27000.0 in the prior quarter.
  • Across five years, Other Working Capital Changes topped out at $1.7 million in Q1 2023 and bottomed at -$1.9 million in Q3 2022.
  • The 5-year median for Other Working Capital Changes is -$27000.0 (2025), against an average of -$45517.8.
  • The largest annual shift saw Other Working Capital Changes crashed 9713.88% in 2022 before it surged 1890.16% in 2023.
  • A 5-year view of Other Working Capital Changes shows it stood at $1.0 million in 2021, then plummeted by 143.36% to -$451618.0 in 2022, then soared by 79.85% to -$91000.0 in 2023, then surged by 430.77% to $301000.0 in 2024, then soared by 45.18% to $437000.0 in 2025.
  • Per Business Quant, the three most recent readings for OPRX's Other Working Capital Changes are $437000.0 (Q3 2025), -$27000.0 (Q2 2025), and $38000.0 (Q1 2025).